David Blanchard
Plus aucun poste en cours
Profil
David Blanchard joined Idenix Pharmaceuticals, Inc. in December 2000 and has been an Interim Chief Financial Officer since April 2007.
Previously, he was Corporate Controller of Idenix Pharmaceuticals from December 2000 to September 2004, Executive Director- Finance from September 2004 to January 2005 and Vice President of Financial Planning and Analysis from January 2005 to March 2007.
Prior to joining Idenix, he was Controller of Hope Webbing Company from 1998 to 2000.
Mr. Blanchard received an MBA and a BS from Nichols College.
Anciens postes connus de David Blanchard
| Sociétés | Poste | Fin |
|---|---|---|
| IDENIX PHARMACEUTICALS INC | Directeur Financier/CFO | 01/06/2007 |
Formation de David Blanchard
| Nichols College | Masters Business Admin |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
